Total Payments
$115,118
2024 Payments
$92.86
Companies
27
Transactions
532
Medicare Patients
2,262
Medicare Billing
$415,667
Payment Breakdown by Category
Other$102,869 (89.4%)
Food & Beverage$7,161 (6.2%)
Travel$4,640 (4.0%)
Consulting$442.50 (0.4%)
Education$6.09 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102,869 | 93 | 89.4% |
| Food and Beverage | $7,161 | 396 | 6.2% |
| Travel and Lodging | $4,640 | 41 | 4.0% |
| Consulting Fee | $442.50 | 1 | 0.4% |
| Education | $6.09 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $78,260 | 231 | $0 (2021) |
| AbbVie Inc. | $14,891 | 44 | $0 (2023) |
| Takeda Pharmaceuticals America, Inc. | $10,922 | 25 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $7,738 | 34 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $618.49 | 30 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $455.74 | 25 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $431.89 | 26 | $0 (2022) |
| Shire North American Group Inc | $373.50 | 31 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $225.69 | 18 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $181.36 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92.86 | 4 | Tris Pharma Inc ($62.75) |
| 2023 | $3,702 | 14 | AbbVie Inc. ($3,648) |
| 2022 | $3,504 | 20 | ABBVIE INC. ($3,300) |
| 2021 | $11,052 | 29 | AbbVie Inc. ($7,942) |
| 2020 | $12,760 | 67 | Allergan, Inc. ($10,419) |
| 2019 | $14,959 | 123 | Allergan Inc. ($13,568) |
| 2018 | $26,383 | 130 | Allergan Inc. ($25,111) |
| 2017 | $42,664 | 145 | Allergan Inc. ($26,237) |
All Payment Transactions
532 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ADHD | ||||||
| 08/05/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: ADHD | ||||||
| 05/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.11 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/24/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: ADHD | ||||||
| 07/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $36.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $36.90 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $24.32 | General |
| Category: PSYCHOLOGY | ||||||
| 02/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $35.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $32.46 | General |
| 11/17/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $2.00 | General |
| 10/13/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Neuropsychiatry | ||||||
| 09/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.77 | General |
| 08/19/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.41 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 412 | 1,513 | $367,865 | $85,705 |
| 2022 | 8 | 697 | 2,486 | $551,830 | $142,381 |
| 2021 | 9 | 588 | 2,091 | $394,732 | $117,941 |
| 2020 | 10 | 565 | 1,418 | $209,953 | $69,639 |
Total Patients
2,262
Total Services
7,508
Medicare Billing
$415,667
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 474 | $127,980 | $39,495 | 30.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 123 | 465 | $92,535 | $21,893 | 23.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 70 | 458 | $115,874 | $16,705 | 14.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Office | 2023 | 37 | 39 | $15,918 | $3,758 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,240 | $1,652 | 26.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Office | 2023 | 19 | 20 | $4,292 | $1,188 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 23 | $4,209 | $828.74 | 19.7% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2023 | 12 | 19 | $817.00 | $185.92 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 526 | $142,020 | $48,581 | 34.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 180 | 788 | $156,812 | $38,998 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 146 | 334 | $61,164 | $17,141 | 28.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Office | 2022 | 74 | 588 | $118,052 | $16,666 | 14.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 135 | $31,050 | $10,373 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $23,296 | $5,882 | 25.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Office | 2022 | 34 | 35 | $14,285 | $3,480 | 24.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 23 | 24 | $5,151 | $1,260 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 621 | $113,643 | $40,358 | 35.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 167 | 635 | $126,365 | $32,573 | 25.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 42 | 216 | $34,560 | $12,069 | 34.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Office | 2021 | 45 | 313 | $43,982 | $9,399 | 21.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 36 | 111 | $25,530 | $8,607 | 33.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 59 | $15,930 | $4,579 | 28.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $14,144 | $3,845 | 27.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 24 | $7,833 | $2,549 | 32.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 51 | $4,335 | $1,532 | 35.3% |
About Dr. David Samuels, DO
Dr. David Samuels, DO is a Psychiatry healthcare provider based in Statesboro, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942333158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Samuels, DO has received a total of $115,118 in payments from pharmaceutical and medical device companies, with $92.86 received in 2024. These payments were reported across 532 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($102,869).
As a Medicare-enrolled provider, Samuels has provided services to 2,262 Medicare beneficiaries, totaling 7,508 services with total Medicare billing of $415,667. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Statesboro, GA
- Active Since 03/14/2007
- Last Updated 04/27/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942333158
Products in Payments
- VRAYLAR (Drug) $92,781
- Trintellix (Drug) $11,098
- LATUDA (Drug) $7,738
- REXULTI (Drug) $476.45
- INGREZZA (Drug) $431.89
- FANAPT (Drug) $297.71
- VIIBRYD (Drug) $256.87
- VYVANSE (Drug) $248.04
- SPRAVATO (Drug) $181.36
- Adzenys XR-ODT (Drug) $161.44
- MYDAYIS (Drug) $156.80
- HETLIOZ (Drug) $153.22
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $100.74
- Fanapt (Drug) $93.23
- Hetlioz (Drug) $74.33
- Dyanavel XR (Drug) $73.29
- Auvelity (Drug) $60.02
- TRINTELLIX (Drug) $54.28
- ABILIFY MAINTENA (Drug) $52.20
- AUSTEDO (Drug) $50.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.